Chronic Pain Medical Cannabis UK: Complete Patient Guide

Is Medical Cannabis Prescribed for Chronic Pain in the UK?

• Yes — chronic pain is one of the most common indications for medical cannabis prescribing in the UK.
• Legal prescriptions have been available since November 2018 for patients who meet clinical criteria.
• A specialist consultant (not a GP) must issue the prescription; NHS prescribing for pain is extremely rare.
• The most common products for pain are CBD:THC ratio oils, full-spectrum oils, and dried flower for vaporisation.

Chronic pain affects an estimated 28 million people in the UK, making it the largest single driver of demand for medical cannabis. For those who have not found relief through conventional treatments, a legally prescribed cannabis medicine can offer meaningful improvements in quality of life.

Qualifying Criteria for Chronic Pain Patients

• Patients must have a documented chronic pain condition lasting more than three months.
• At least two prior treatment failures must be evidenced — e.g. opioids, NSAIDs, gabapentinoids, or physiotherapy.
• A formal diagnosis from an NHS or private specialist is required alongside a full medical history.
• Patients with substance misuse histories may face additional assessment but are not automatically excluded.

The eligibility bar for medical cannabis is deliberately high to ensure it is used only when appropriate. Patients who prepare well — gathering records, documenting treatment history — tend to have smoother and faster consultations.

Types of Products Prescribed for Chronic Pain in the UK

• Full-spectrum cannabis oils (e.g. THC:CBD 1:1 or higher THC) are commonly prescribed for moderate to severe pain.
• Dried cannabis flower, vaporised using a medical-grade device, provides faster onset for breakthrough pain.
• CBD-dominant products are used as adjuncts or for patients who cannot tolerate THC side effects.
• Feco (full extract cannabis oil) and capsules are used for patients who prefer oral dosing without vaporisation.

UK prescribers tailor product selection to the individual patient’s pain type, severity, lifestyle, and prior cannabis exposure. Starting low and titrating slowly is the standard approach, particularly for THC-naive patients.

Costs and NHS vs Private Routes for UK Pain Patients

• NHS prescriptions for chronic pain: extremely rare, with most applications declined at CCG/ICB level.
• Private specialist consultation: £150–£300 initial fee at the main UK clinic networks.
• Monthly medication: £80–£250 depending on product, dose, and dispensing pharmacy.
• Some UK trusts are piloting NHS-funded programmes; check with your local ICB whether any are active near you.

The private clinic route remains the realistic pathway for the overwhelming majority of UK chronic pain patients. Patients who engage consistently with follow-up care and keep detailed symptom diaries tend to achieve the best clinical outcomes.